Traders and Investors,

The markets took a beating yesterday with the averages down around 2.5%, and that's exactly why we love small caps - they don't care what the market is doing.

In fact, while the big boys like AAPL, FB and AMZN get ripped apart, small cap tickers often thrive as capital rotates into these names.

In any case, the futures are indicating a major market bounce today, and I've got just the right medical marijuana play for us.

MQPXF is the ticker, get in on your screen immediately.

MQPXF closed yesterday at $0.2350. It is sitting right at multi-month support, with a multiple bottom chart pattern.

It recently traded as high as $0.64 back in January.

We think this chart is poised for a major move higher off what appears to be super strong support, and the next resistance level could be around $0.40 - the high it bounced to back in February.

In other words, there is a ton of potential in MQPXF, possibly 70%+ short term upside.

And its liquidity is good with a tight level 2, so traders will love to sink their teeth into this one.




Matica Enterprises, Inc is listed on OTC Pink (MQPXF), the Canadian Stock Exchange (MMJ) and on the Frankfurt Exchange (39N), making it a well watched company around the globe.  

MQPXF is focused on the Medical Marijuana sector.

Recent developments in the regulation of marijuana have brought new opportunities to the Canadian marketplace.

Here are some major facts that will open your eyes to the upside here...

• Spending on legal cannabis worldwide is expected to hit $57 billion by 2027.
• The adult use market will cover 67% of the spending; medical marijuana will take up the remaining 33%
• Per their latest interim financial report, MQPXF has $1.45m cash on hand, and total assets of almost $3.6m; with just $250k total current liabilities. Total shareholder's equity is in excess of $3.5m!!!
• The Company's assets are up 774% over the prior 4 quarters.
• A readiness for ACMPR (Canada's Access to Cannabis for Medical Purposes Regulations) has been submitted for new major production facility.

Dorval, Quebec, Canada

Matica is nearing completion of a new 10,000 sq. ft., cannabis growing facility in Dorval Quebec. Once the facility is completed the Company will be submitting a Photographic-Evidence video to Health Canada to request our cultivation license.

The state of the art facility is fully climate controlled with automated plant nutrient systems to ensure the highest quality product.

Under the agreement with RoyalMax Biotechnology Canada Inc., Matica is to become a majority owner (70%) of a late stage applicant under the Access to Cannabis for Medical Purposes Regulation - ACMPR.

The RoyalMax facility is located in an industrial park in Dorval, Quebec. Dorval is a mainly industrial suburb on the West Island of Montreal. The facility is near the Montreal−Pierre Elliot Trudeau International Airport and the Dorval Train Station. It is also very near highways 20, 520 and 13. Matica management has negotiated, on favourable terms, a 20 year extension to the current lease.

Nova Scotia MMPR

In October 2014 Matica signed a definitive agreement to earn a fifty percent interest in THC Dispensaries Canada, Inc (“THCD”), a Nova Scotia applicant under the then, MMPR. In December 2015 Matica filed a Notice of Civil Claim in the Vancouver Registry of the Supreme Court of British Columbia in an effort to recoup funds and other damages suffered by Matica.

The Company has reached a settlement where unrelated third party has agreed to purchase all of the outstanding shares of THCD and complete the build out of THCD’s facility. THCD is one of several such facilities that the third party has engaged and is preparing for pre-licence inspection. Matica is to receive shares of the third party at a deemed value of $700,000 in two tranches of $350,000 each. The first tranche is to be issued on closing and the second and final tranche is to be issued on the date of issuance by Health Canada of an ACMPR cultivation license in the name of THCD.

Other Marijuana Projects

On September 27, 2017, Matica announced signing a non-binding letter of intent (“LOI”) for Matica to become a majority owner of a late stage ACMPR application in southwestern Ontario. We are continuing our due diligence on the project. The application is for a 13,000 square foot building which could be easily expanded to 24,000 square feet by extending it to an adjoining building. The project sits on 14 acres of largely vacant land. Matica is contemplating building a 400,000 square foot facility on the property at a later date. Furthermore, Matica has negotiated a favourable purchase option for the entire property.

You can learn more about MQPXF at their website https://www.maticaenterprises.com

As Matica nears the completion of its cannabis growing facility in Dorval, management recognizes the acute need for alternative cannabis delivery systems, including pain relief topicals.  With this acquisition Matica can direct research to produce new topical products such as balms, creams and salves.  The target company is based just outside of Montreal and is a leader in sustainable, clean, health and personal care products.  Using proprietary mineral and plant based suspension technologies which can create unique alternative clean ingredients, Matica intends to develop revolutionary topical products within the cannabis space.

In Conclusion...

MQPXF appears to be a "best of breed" MMJ Company. With $1.45m cash on hand, and more than $3.5m net assets, their financials are rock solid.

And the chart is a thing of beauty. It closed yesterday right at long term support - with a well defined multiple bottom.

Given it has retraced over 60% from its recent highs, we think MQPXF is primed for a move higher. A move that has the potential to deliver 70%+ short term upside.

The time is now. Get MQPXF on your screen now, and be ready for an exciting trading day ahead.


All the best.

SmallCapMomo.com